We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 25 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Sense Products is a food supplement company that currently have 5 products on the market; Sense for a night out (alcohol), Sense for nicotine lovers (smokers), Sense for cholesterol, Sense for city living (busy lives) and Sense for weight warriors.
days to go: Expired investment: £200,000
Yumbles is a leading UK online marketplace for artisan food. It currently connects over 600 independent food makers directly with consumers. The company is targeting the UK’s estimated £10bn+ UK Speciality Food & Drink market, having seen £1m+ sales in the last 12 months resulting in £400k+ revenue.
days to go: Expired investment: £262,080
Market Porter is a food-tech platform connecting independant food producers, such as butchers and farm shops, with the consumers. The company are the only food-tech platform which work on a national scale instead of just locally. They source out the best small scale producers with top quality and taste, all delivered straight to your door. 
days to go: Expired investment: £885,000
The Wine List (WL) gives confidence to wine lovers through a home wine course. The company argues that 20% of the UK's wine drinkers fall into a cohort that is actively engaged, spend at the higher end of the market, and frequently drink from a variety of sources. But less than 20,000 people don't have the requisite knowledge about different wine styles and tastes. WL aims to change this scenario by offering a home wine course to customers where alongside their wine lessons, they also get two bottles of wine to practice their skills on. The company has shipped 20,000+ bottles of wine and witnessed revenues of £298,000 in April-October 2020. WL is also building a digital content platform that will offer best in class video lessons, with learning quizzes to reinforce knowledge. The company has featured in Metro, Evening Standard, and Courier. It will use the investment to increase content production, wine delivery and scale into 2021.

Pitch Rated

38%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £505,494
East London Liquor Company export from east London to 20 countries worldwide. They have plans to launch in Ibiza, Toronto, Los angles, New York and Shanghai.  They also own their own restaurant. Since 2014 they have grown there team from 4 to 30 people. London dry gin has won many award and the East London Liquor Company produces over 12,000 bottles of gin a month.
days to go: Expired investment: £1,326,450
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph